Louisiana 2020 Regular Session

Louisiana House Bill HB616

Introduced
2/28/20  
Introduced
2/28/20  
Refer
2/28/20  
Refer
3/9/20  

Caption

Provides for disclosure of prescription drug cost information

Companion Bills

No companion bills found.

Similar Bills

TX HB2536

Relating to transparency related to drug costs.

MA H1176

Relative to promoting comprehensive transparency in the pharmaceutical industry

MA S732

Relative to promoting comprehensive transparency in the pharmaceutical industry

TX HB1033

Relating to prescription drug price disclosure; authorizing a fee; providing an administrative penalty.

CT HB05384

An Act Concerning Prescription Drug Costs.

LA HB436

Requires drug manufacturers to provide information regarding prescription drug prices (EN NO IMPACT See Note)

WI SB50

Health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE)

WI AB62

Health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE)